2026 Q2 -tulosraportti
Vain PDF
10 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·22 t sittenA bit of gossip from Germany while we wait for the batch to be released. There has just been a lawsuit in Frankfurt, where a woman wanted to have the opportunity to retain her status in the healthcare system regarding flower medicine. She did not win. By mistake or perhaps it was lobbying, it was also interpreted as if she and all others who had been treated with flower medicine after this ruling should be considered new patients, and then would have to go into quarantine anyway. This has been rectified again, and as of August 28th, a message has been sent out that these patient groups are free from quarantine. As long as those who have been treated with flowers before July 30th are free from quarantine, then it's good for Weeco Astrum10/10 because more bottles will be handed over the counter from this segment. https://bdcan.de/cannabisblueten-gkv/
·2 päivää sittenI think it's a shame that this feed is completely polluted by 3D's assumptions and updates about inventory etc. It's very difficult to get an overview when there's incessant posting at all times. Could one perhaps just provide input once every 14 days? @3DSnehild, I think you should come up with some news yourself, I would welcome that, and I would also welcome others spending time to come up with news about this stock. I also think it's strange that you're angry that I spend time looking for news. Only because I have spent time looking for news, do you know that the flower medicine has lost its subsidy in Germany first on July 10th and later clarified as of July 29th, 2026. It is absolutely correct that it shouldn't have been me who broke this news. But it should have been the management who came with this news, because this news would most likely have an impact on the stock price, because Stenocare can now look forward to a larger income in Germany, which no one had expected, because this law of July 10th came suddenly, and therefore some of these will be prescribed Weeco Astrum 10/10 which is an unexpected income for Stenocare. But because it is me who broke this news and not Stenocare, it has naturally had no impact on the stock price. But if Stenocare had fulfilled their disclosure obligation, it would be likely that the stock price would have risen, due to this unexpected extra income. This has a name: asymmetric information. So yes, if Stenocare had come with this information instead of me, the stock would have been worth much more than it is now. You must take your complaints to the right place if you want it to be rectified, or keep quiet.- ·3 päivää sitten · MuokattuNow that I have informed how medical cannabis should be handled, and Muldyr made me go into detail, you have all received the same knowledge about how expensive and difficult it is when a pharmacy wants to stock Weeco Astrum10/10 (as well as other cannabis products). The pharmacies that stock Weeco Astrum 10/10 are where doctors prescribe Weeco Astrum 10/10. It is only because many people buy Weeco Astrum 10/10 that they have the oil in stock. If only a few prescriptions were issued, Weeco Astrum 10/10 would be an order item. That's the only reason I know that Stenocare has sold well in Germany in Q2 because many pharmacies have had the oil in stock since May 13th, when I started performing stock status checks. Based on this knowledge, can you then understand that in this case it is secondary knowledge how many bottles they sell per pharmacy? Here is the most important knowledge: do they sell anything or not. Based on the above, we can see that they do, and they have done so since Weeco Pharma took over the task from ADREX Pharma. When I see that it's sold out, it means that the stock cannot keep up in the areas where it's sold out, and when it's quickly refilled within 24 hours, it means they expect additional sales within a short time. In this area, so many prescriptions are being written that the stock cannot keep up. This is the reason why I continue to perform stock status checks, and I will continue until it no longer makes sense. It is a rarity that one can follow in real time, but we can here, so therefore it would be more than foolish to stop now.Right now nothing is happening in France because parliament is on holiday and will return again in September. What we are waiting for now is for President Macron to sign the decree, so they can move forward with their roadmap for medical cannabis.
- ·3 päivää sittenThis evening, all Canngo's pharmacies have received Weeco Astrum 10/10 back in stock. It was one pharmacy that reported being sold out yesterday afternoon.I'm just reminding you that in a post you yourself very clearly wrote that one cannot use these statements to estimate what the sales are. And yet, directly against your own advice, that is exactly what you are doing and have always done every day, constantly and all the time. So there is a reason why all your predictions and estimates have failed 100%, and that on all points. If you had then learned just a little from your mistakes and adjusted the method just a little, then I might have been able to understand you. But you don't. You relentlessly continue to use a method that has proven unusable and consequently, one cannot use your posts for anything at all.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
Vain PDF
10 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·22 t sittenA bit of gossip from Germany while we wait for the batch to be released. There has just been a lawsuit in Frankfurt, where a woman wanted to have the opportunity to retain her status in the healthcare system regarding flower medicine. She did not win. By mistake or perhaps it was lobbying, it was also interpreted as if she and all others who had been treated with flower medicine after this ruling should be considered new patients, and then would have to go into quarantine anyway. This has been rectified again, and as of August 28th, a message has been sent out that these patient groups are free from quarantine. As long as those who have been treated with flowers before July 30th are free from quarantine, then it's good for Weeco Astrum10/10 because more bottles will be handed over the counter from this segment. https://bdcan.de/cannabisblueten-gkv/
- ·2 päivää sittenI think it's a shame that this feed is completely polluted by 3D's assumptions and updates about inventory etc. It's very difficult to get an overview when there's incessant posting at all times. Could one perhaps just provide input once every 14 days? @3DSnehild, I think you should come up with some news yourself, I would welcome that, and I would also welcome others spending time to come up with news about this stock. I also think it's strange that you're angry that I spend time looking for news. Only because I have spent time looking for news, do you know that the flower medicine has lost its subsidy in Germany first on July 10th and later clarified as of July 29th, 2026. It is absolutely correct that it shouldn't have been me who broke this news. But it should have been the management who came with this news, because this news would most likely have an impact on the stock price, because Stenocare can now look forward to a larger income in Germany, which no one had expected, because this law of July 10th came suddenly, and therefore some of these will be prescribed Weeco Astrum 10/10 which is an unexpected income for Stenocare. But because it is me who broke this news and not Stenocare, it has naturally had no impact on the stock price. But if Stenocare had fulfilled their disclosure obligation, it would be likely that the stock price would have risen, due to this unexpected extra income. This has a name: asymmetric information. So yes, if Stenocare had come with this information instead of me, the stock would have been worth much more than it is now. You must take your complaints to the right place if you want it to be rectified, or keep quiet.
- ·3 päivää sitten · MuokattuNow that I have informed how medical cannabis should be handled, and Muldyr made me go into detail, you have all received the same knowledge about how expensive and difficult it is when a pharmacy wants to stock Weeco Astrum10/10 (as well as other cannabis products). The pharmacies that stock Weeco Astrum 10/10 are where doctors prescribe Weeco Astrum 10/10. It is only because many people buy Weeco Astrum 10/10 that they have the oil in stock. If only a few prescriptions were issued, Weeco Astrum 10/10 would be an order item. That's the only reason I know that Stenocare has sold well in Germany in Q2 because many pharmacies have had the oil in stock since May 13th, when I started performing stock status checks. Based on this knowledge, can you then understand that in this case it is secondary knowledge how many bottles they sell per pharmacy? Here is the most important knowledge: do they sell anything or not. Based on the above, we can see that they do, and they have done so since Weeco Pharma took over the task from ADREX Pharma. When I see that it's sold out, it means that the stock cannot keep up in the areas where it's sold out, and when it's quickly refilled within 24 hours, it means they expect additional sales within a short time. In this area, so many prescriptions are being written that the stock cannot keep up. This is the reason why I continue to perform stock status checks, and I will continue until it no longer makes sense. It is a rarity that one can follow in real time, but we can here, so therefore it would be more than foolish to stop now.Right now nothing is happening in France because parliament is on holiday and will return again in September. What we are waiting for now is for President Macron to sign the decree, so they can move forward with their roadmap for medical cannabis.
- ·3 päivää sittenThis evening, all Canngo's pharmacies have received Weeco Astrum 10/10 back in stock. It was one pharmacy that reported being sold out yesterday afternoon.I'm just reminding you that in a post you yourself very clearly wrote that one cannot use these statements to estimate what the sales are. And yet, directly against your own advice, that is exactly what you are doing and have always done every day, constantly and all the time. So there is a reason why all your predictions and estimates have failed 100%, and that on all points. If you had then learned just a little from your mistakes and adjusted the method just a little, then I might have been able to understand you. But you don't. You relentlessly continue to use a method that has proven unusable and consequently, one cannot use your posts for anything at all.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
2026 Q2 -tulosraportti
Vain PDF
10 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·22 t sittenA bit of gossip from Germany while we wait for the batch to be released. There has just been a lawsuit in Frankfurt, where a woman wanted to have the opportunity to retain her status in the healthcare system regarding flower medicine. She did not win. By mistake or perhaps it was lobbying, it was also interpreted as if she and all others who had been treated with flower medicine after this ruling should be considered new patients, and then would have to go into quarantine anyway. This has been rectified again, and as of August 28th, a message has been sent out that these patient groups are free from quarantine. As long as those who have been treated with flowers before July 30th are free from quarantine, then it's good for Weeco Astrum10/10 because more bottles will be handed over the counter from this segment. https://bdcan.de/cannabisblueten-gkv/
- ·2 päivää sittenI think it's a shame that this feed is completely polluted by 3D's assumptions and updates about inventory etc. It's very difficult to get an overview when there's incessant posting at all times. Could one perhaps just provide input once every 14 days? @3DSnehild, I think you should come up with some news yourself, I would welcome that, and I would also welcome others spending time to come up with news about this stock. I also think it's strange that you're angry that I spend time looking for news. Only because I have spent time looking for news, do you know that the flower medicine has lost its subsidy in Germany first on July 10th and later clarified as of July 29th, 2026. It is absolutely correct that it shouldn't have been me who broke this news. But it should have been the management who came with this news, because this news would most likely have an impact on the stock price, because Stenocare can now look forward to a larger income in Germany, which no one had expected, because this law of July 10th came suddenly, and therefore some of these will be prescribed Weeco Astrum 10/10 which is an unexpected income for Stenocare. But because it is me who broke this news and not Stenocare, it has naturally had no impact on the stock price. But if Stenocare had fulfilled their disclosure obligation, it would be likely that the stock price would have risen, due to this unexpected extra income. This has a name: asymmetric information. So yes, if Stenocare had come with this information instead of me, the stock would have been worth much more than it is now. You must take your complaints to the right place if you want it to be rectified, or keep quiet.
- ·3 päivää sitten · MuokattuNow that I have informed how medical cannabis should be handled, and Muldyr made me go into detail, you have all received the same knowledge about how expensive and difficult it is when a pharmacy wants to stock Weeco Astrum10/10 (as well as other cannabis products). The pharmacies that stock Weeco Astrum 10/10 are where doctors prescribe Weeco Astrum 10/10. It is only because many people buy Weeco Astrum 10/10 that they have the oil in stock. If only a few prescriptions were issued, Weeco Astrum 10/10 would be an order item. That's the only reason I know that Stenocare has sold well in Germany in Q2 because many pharmacies have had the oil in stock since May 13th, when I started performing stock status checks. Based on this knowledge, can you then understand that in this case it is secondary knowledge how many bottles they sell per pharmacy? Here is the most important knowledge: do they sell anything or not. Based on the above, we can see that they do, and they have done so since Weeco Pharma took over the task from ADREX Pharma. When I see that it's sold out, it means that the stock cannot keep up in the areas where it's sold out, and when it's quickly refilled within 24 hours, it means they expect additional sales within a short time. In this area, so many prescriptions are being written that the stock cannot keep up. This is the reason why I continue to perform stock status checks, and I will continue until it no longer makes sense. It is a rarity that one can follow in real time, but we can here, so therefore it would be more than foolish to stop now.Right now nothing is happening in France because parliament is on holiday and will return again in September. What we are waiting for now is for President Macron to sign the decree, so they can move forward with their roadmap for medical cannabis.
- ·3 päivää sittenThis evening, all Canngo's pharmacies have received Weeco Astrum 10/10 back in stock. It was one pharmacy that reported being sold out yesterday afternoon.I'm just reminding you that in a post you yourself very clearly wrote that one cannot use these statements to estimate what the sales are. And yet, directly against your own advice, that is exactly what you are doing and have always done every day, constantly and all the time. So there is a reason why all your predictions and estimates have failed 100%, and that on all points. If you had then learned just a little from your mistakes and adjusted the method just a little, then I might have been able to understand you. But you don't. You relentlessly continue to use a method that has proven unusable and consequently, one cannot use your posts for anything at all.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt